Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Buy
63
MKC Quote, Financials, Valuation and Earnings
Last price:
$81.26
Seasonality move
:
3.91%
Day range:
$80.92 - $82.85
52-week range:
$66.88 - $86.24
Dividend yield:
2.08%
P/E ratio:
28.26x
P/S ratio:
3.30x
P/B ratio:
4.07x
Volume:
2.1M
Avg. volume:
2.5M
1-year change:
7.35%
Market cap:
$22.1B
Revenue:
$6.7B
EPS (TTM):
$2.91
Analysts' Opinion
-
Consensus RatingMcCormick & has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $83.77, McCormick & has an estimated upside of 1.85% from its current price of $82.25.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $67.00 representing 100% downside risk from its current price of $82.25.
Fair Value
-
According to the consensus of 14 analysts, McCormick & has 1.85% upside to fair value with a price target of $83.77 per share.
MKC vs. S&P 500
-
Over the past 5 trading days, McCormick & has overperformed the S&P 500 by 3.61% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
McCormick & does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
McCormick & has grown year-over-year revenues for 2 quarters straight. In the most recent quarter McCormick & reported revenues of $1.6B.
Earnings Growth
-
McCormick & earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter McCormick & reported earnings per share of $0.60.
Enterprise value:
26.3B
EV / Invested capital:
2.69x
Price / LTM sales:
3.30x
EV / EBIT:
23.94x
EV / Revenue:
3.91x
PEG ratio (5yr expected):
2.55x
EV / Free cash flow:
40.51x
Price / Operating cash flow:
34.17x
Enterprise value / EBITDA:
19.99x
Gross Profit (TTM):
$2.6B
Return On Assets:
6.03%
Net Income Margin (TTM):
11.67%
Return On Equity:
14.63%
Return On Invested Capital:
8.01%
Operating Margin:
14.03%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-28 | 2024-02-28 | 2025-02-28 | 2024-02-28 | 2025-02-28 | |
| Income Statement | ||||||
| Revenue | $6.4B | -- | $6.7B | -- | $1.6B | |
| Gross Profit | $2.3B | -- | $2.6B | -- | $604M | |
| Operating Income | $912M | -- | $1.1B | -- | $225.2M | |
| EBITDA | $1.2B | -- | $1.3B | -- | $288.8M | |
| Diluted EPS | $2.47 | -- | $2.91 | -- | $0.60 | |
| Period Ending | 2021-02-28 | 2022-02-28 | 2023-02-28 | 2024-02-28 | 2025-02-28 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2B | $2.2B | $2.4B | -- | $2B | |
| Total Assets | $12.7B | $12.9B | $13.2B | -- | $12.9B | |
| Current Liabilities | $2.4B | $3.1B | $3.3B | -- | $3.1B | |
| Total Liabilities | $8.5B | $8.3B | $8.3B | -- | $7.5B | |
| Total Equity | $4.2B | $4.6B | $4.9B | -- | $5.4B | |
| Total Debt | $5.6B | $5.4B | $5.2B | -- | $4.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-28 | 2024-02-28 | 2025-02-28 | 2024-02-28 | 2025-02-28 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $737M | -- | $899M | -- | $115.5M | |
| Cash From Investing | -$164.2M | -- | -$244.3M | -- | -$37.1M | |
| Cash From Financing | -$536.3M | -- | -$670.6M | -- | -$155.2M | |
| Free Cash Flow | $457.2M | -- | $649M | -- | $78.4M | |
MKC
Sector
Market Cap
$22.1B
$264.2M
Price % of 52-Week High
95.37%
73.33%
Dividend Yield
2.08%
0%
Shareholder Yield
2.48%
3.01%
1-Year Price Total Return
7.35%
-13.26%
Beta (5-Year)
0.751
0.413
Dividend yield:
2.08%
Annualized payout:
$1.68
Payout ratio:
58.49%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$81.16
200-day SMA
Buy
Level
$77.60
Bollinger Bands (100)
Buy
Level
75.23 - 81.01
Chaikin Money Flow
Buy
Level
212.4M
20-day SMA
Buy
Level
$81.49
Relative Strength Index (RSI14)
Buy
Level
56.84
ADX Line
Sell
Level
18.2
Williams %R
Sell
Level
-12.7841
50-day SMA
Buy
Level
$79.16
MACD (12, 26)
Buy
Level
0.56
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
258.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7317)
Sell
CA Score
(Annual)
Level (-0.3396)
Buy
Beneish M-Score
(Annual)
Level (-2.5487)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.1118)
Buy
Piotroski F Score
(Annual)
Level (9)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
In its 135-year history, McCormick has become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond consumers, McCormick's customer base includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers. And its reach is extensive, with nearly 40% of sales generated beyond its home turf to 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and Cholula, among others.
Stock Forecast FAQ
In the current month, MKC has received 4 Buy ratings 10 Hold ratings, and 0 Sell ratings. The MKC average analyst price target in the past 3 months is $83.77.
-
Where Will McCormick & Stock Be In 1 Year?
According to analysts, the consensus estimate is that McCormick & share price will rise to $83.77 per share over the next 12 months.
-
What Do Analysts Say About McCormick &?
Analysts are divided on their view about McCormick & share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that McCormick & is a Sell and believe this share price will drop from its current level to $67.00.
-
What Is McCormick &'s Price Target?
The price target for McCormick & over the next 1-year time period is forecast to be $83.77 according to 14 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is MKC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for McCormick & is a Hold. 10 of 14 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MKC?
You can purchase shares of McCormick & via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase McCormick & shares.
-
What Is The McCormick & Share Price Today?
McCormick & was last trading at $81.26 per share. This represents the most recent stock quote for McCormick &. Yesterday, McCormick & closed at $82.25 per share.
-
How To Buy McCormick & Stock Online?
In order to purchase McCormick & stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Too Late to Buy United Airlines Stock?
United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…
3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
GATE alert for Apr 2
Marblegate Acquisition [GATE] is up 86.64% over the past day.
Buy
52
NUTX alert for Apr 2
Nutex Health [NUTX] is up 5.41% over the past day.
Buy
75
CORT alert for Apr 2
Corcept Therapeutics [CORT] is down 8.84% over the past day.
